BMC Cancer
- LIANG Y, Zhong D, Zhang Z, Su Y, et al
Correction: Impact of preoperative antiviral therapy on the prognosis of
hepatitis B virus-related hepatocellular carcinoma.
BMC Cancer. 2024;24:343.
Clin Infect Dis
- GREBELY J
Point-of-care testing for hepatitis C infection: A critical building block for
the foundation to achieve elimination.
Clin Infect Dis. 2024 Mar 21:ciae156. doi: 10.1093.
- MCCARTNEY EM, Ralton L, Dawe J, Richmond J, et al
Point of care testing for hepatitis C in the priority settings of mental health,
prisons and drug & alcohol facilities - the PROMPt Study.
Clin Infect Dis. 2024 Mar 21:ciae155. doi: 10.1093.
J Hepatol
- TONNERRE P, Baumert TF
Unraveling the liver antiviral immunity in functional cure of chronic hepatitis B
using scRNASeq.
J Hepatol. 2024 Mar 19:S0168-8278(24)00200-9. doi: 10.1016/j.jhep.2024.
- THURSZ M, Mathurin P
Targeting IL-1 in severe alcohol-related hepatitis; how many frogs will we need
to kiss to find an effective therapy?
J Hepatol. 2024 Mar 16:S0168-8278(24)00163-6. doi: 10.1016/j.jhep.2024.
- KONDILI LA, Lazarus JV, Jepsen P, Murray F, et al
Inequities in primary liver cancer in Europe: The state of play.
J Hepatol. 2024;80:645-660.
J Med Virol
- CHEN J, Shen L, Guo Q, Ma S, et al
The downregulation of Tapasin in dendritic cell regulates CD8(+) T cell autophagy
to hamper hepatitis B viral clearance in the induced pluripotent stem
cell-derived hepatocyte organoid.
J Med Virol. 2024;96:e29546.
- ZHA G, Chen Z, Wu N, Huang T, et al
Clinical characteristics and immunogenicity after Omicron breakthrough infection
in patients with chronic hepatitis B infection: A longitudinal observational
study.
J Med Virol. 2024;96:e29548.
- MIUMA S, Miyaaki H, Ichikawa T, Matsuzaki T, et al
Non-liver-related mortality in the DAA era: Insights from post-SVR patients with
and without previous HCC history.
J Med Virol. 2024;96:e29432.
J Virol
- MCCOULLOUGH LC, Sadauskas T, Sozzi V, Mak KY, et al
The in vitro replication phenotype of hepatitis B virus (HBV) splice variants Sp3
and Sp9 and their impact on wild-type HBV replication.
J Virol. 2024 Mar 19:e0153823. doi: 10.1128/jvi.01538.
- LI Y, Lemon SM
Biochemical analysis of the host factor activity of ZCCHC14 in hepatitis A virus
replication.
J Virol. 2024 Mar 19:e0005724. doi: 10.1128/jvi.00057.
- TAMURA T, Yamamoto H, Ogino S, Morioka Y, et al
A rapid and versatile reverse genetics approach for generating recombinant
positive-strand RNA viruses that use IRES-mediated translation.
J Virol. 2024;98:e0163823.
- BERKE JM, Tan Y, Sauviller S, Wu D-t, et al
Class A capsid assembly modulator apoptotic elimination of hepatocytes with high
HBV core antigen level in vivo is dependent on de novo core protein translation.
J Virol. 2024;98:e0150223.
Lancet
- COUSINS S
Egypt's hepatitis success story.
Lancet. 2024;403:1011-1012.
PLoS Pathog
- KHALFI P, Denis Z, McKellar J, Merolla G, et al
Comparative analysis of human, rodent and snake deltavirus replication.
PLoS Pathog. 2024;20:e1012060.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016